Pembrolizumab lenvatinib in metastatic uterine carcinosarcoma cohort: safety and efficacy from the french multicenter early access program subgroup (LARENA study)

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Clémence Allirol-Binet, Laura Mansi, Maria Kfoury, Léa Muzellec, Julien Grenier, Patrick Bouchaert, Mathilde Airoldi, Brunhilde Hanvic, Claire Gervais, Sarah BETRIAN-LAGARDE, Marc‐Antoine Benderra, Marie Chaix
+5 more Thomas Collot, Pauline Corbaux, Delphine Garbay, Mamadou Diallo, Imen Harhira
DOI: 10.1016/j.ijgc.2025.103032
Cited by: 0

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Uterine Myomas and Treatments

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103032–103032
Publication date
1 February 2026
Language
EN